Maven Securities LTD Takes Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Maven Securities LTD bought a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 25,000 shares of the company's stock, valued at approximately $529,000.

Other hedge funds have also added to or reduced their stakes in the company. AlphaCentric Advisors LLC acquired a new position in shares of Surgery Partners during the fourth quarter valued at about $374,000. Northern Trust Corp raised its position in Surgery Partners by 2.1% in the fourth quarter. Northern Trust Corp now owns 761,790 shares of the company's stock worth $16,127,000 after acquiring an additional 15,657 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Surgery Partners by 3.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company's stock worth $6,107,000 after acquiring an additional 5,551 shares during the period. Norges Bank bought a new position in shares of Surgery Partners during the 4th quarter worth $15,796,000. Finally, E. Ohman J or Asset Management AB lifted its holdings in Surgery Partners by 40.3% during the 4th quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company's stock worth $26,317,000 after purchasing an additional 357,023 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on SGRY. Macquarie dropped their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research report on Tuesday, March 11th. Benchmark reiterated a "buy" rating and issued a $35.00 price objective on shares of Surgery Partners in a report on Monday, April 21st. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $34.75.

Insiders Place Their Bets

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the sale, the insider now owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. This trade represents a 4.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the transaction, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. The trade was a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.30% of the stock is owned by corporate insiders.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY traded down $0.26 during midday trading on Monday, hitting $23.69. The company had a trading volume of 153,087 shares, compared to its average volume of 1,089,211. The business's 50-day simple moving average is $22.55 and its 200-day simple moving average is $23.15. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The stock has a market cap of $3.04 billion, a price-to-earnings ratio of -49.35, a price-to-earnings-growth ratio of 19.21 and a beta of 1.96. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $776.00 million during the quarter, compared to analysts' expectations of $777.77 million. During the same period in the previous year, the business posted $0.10 EPS. The company's revenue for the quarter was up 8.2% compared to the same quarter last year. On average, research analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.